Niquitin Mint (Nicotine)

Niquitin Mint, a nicotinic receptor agonist, is used in smoking cessation to alleviate nicotine withdrawal.

• Smoking cessation: reduces cravings and withdrawal symptoms, supporting adults who want to stop smoking by delivering a measured dose of nicotine through an oral mint.
• Nicotine dependence: provides controlled nicotine exposure to ease the transition away from cigarettes, helping to stabilize plasma nicotine levels and minimize abrupt discontinuation effects.
• Relapse prevention: helps maintain abstinence by managing occasional urges during the quitting process, offering a discreet, on‑the‑go option for short‑term nicotine replacement.

• Nicotine acts as an agonist at nicotinic acetylcholine receptors (nAChRs) in the central nervous system. By binding to these ligand‑gated ion channels, it stimulates dopamine release in reward pathways, which mitigates the deficit caused by abrupt cessation of tobacco smoking. The resulting partial activation of nAChRs reduces withdrawal intensity and craving, allowing the user to gradually taper nicotine exposure.

Niquitin Mint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Mouth irritation: mild soreness or tingling in the oral cavity.
• Nausea: feeling of queasiness after use.
• Headache: mild to moderate head discomfort.
• Dizziness: transient light‑headed sensation.

Serious or Rare Side Effects

• Cardiovascular events: chest pain or palpitations.
• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Hypertension: elevated blood pressure.

When using Niquitin Mint, certain precautions should be observed to ensure safe and effective use.

• Age restriction: not recommended for individuals under 18 years of age.
• Cardiovascular disease: use with caution in patients with heart conditions or hypertension.
• Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited.
• Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously to prevent excess nicotine exposure.
• Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Niquitin Mint can interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis.
• Certain antidepressants (e.g., bupropion): can heighten seizure risk when combined with nicotine.

Moderate Interactions (Monitor Closely)

• Caffeine: nicotine may enhance stimulant effects, leading to jitteriness.
• Beta‑blockers: nicotine can counteract blood pressure‑lowering effects.
• Antipsychotics: nicotine may alter plasma levels of some agents, requiring monitoring.